Sökning: onr:"swepub:oai:DiVA.org:umu-200447" >
Circulating Isovale...
Circulating Isovalerylcarnitine and Lung Cancer Risk : evidence from Mendelian Randomization and Prediagnostic Blood Measurements
-
- Smith-Byrne, Karl (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Cerani, Agustin (författare)
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, QC, Montreal, Canada
-
- Guida, Florence (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
visa fler...
-
- Zhou, Sirui (författare)
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, QC, Montreal, Canada
-
- Agudo, Antonio (författare)
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, Spain
-
- Aleksandrova, Krasimira (författare)
- Nutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany; University of Potsdam, Institute of Nutritional Science, Potsdam, Germany
-
- Barricarte, Aurelio (författare)
- Navarra Institute for Health Research (IdiSNA) Pamplona, Spain; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain
-
- Barranco, Miguel Rodríguez (författare)
- CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
-
- Bochers, Christoph H. (författare)
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, QC, Montreal, Canada; University of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada/Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada
-
- Gram, Inger Torhild (författare)
- Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, Arctic University of Norway, Norway
-
- Han, Jun (författare)
- University of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada/Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada
-
- Amos, Christopher I. (författare)
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, TX, Houston, United States
-
- Hung, Rayjean J. (författare)
- Prosserman Centre for Health Research, Mount Sinai Hospital, Toronto, Canada
-
- Grankvist, Kjell (författare)
- Umeå universitet,Klinisk kemi
-
- Nøst, Therese Haugdhal (författare)
- Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, Arctic University of Norway, Norway
-
- Imaz, Liher (författare)
- Ministry of Health of the Basque Government, Public Health Division of Gipuzkoa, Donostia-San Sebastian, Spain; Biodonostia Health Research Institute, Donostia-San Sebastian, Spain
-
- Chirlaque-López, María Dolores (författare)
- CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain
-
- Johansson, Mikael (författare)
- Umeå universitet,Onkologi
-
- Kaaks, Rudolf (författare)
- German Cancer Research Center (DKFZ), Department of Cancer Epidemiology, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, Member of the German Center for Lung Research (DZL), Germany
-
- Kühn, Tilman (författare)
- German Cancer Research Center (DKFZ), Department of Cancer Epidemiology, Heidelberg, Germany
-
- Martin, Richard M. (författare)
- Clinical Epidemiology & Public Health, University of Bristol, Bristol, United Kingdom
-
- McKay, James D. (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Pala, Valeria (författare)
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
-
- Robbins, Hilary A. (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Sandanger, Torkjel M. (författare)
- Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, Arctic University of Norway, Norway
-
- Schibli, David (författare)
- University of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada/Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada
-
- Schulze, Matthias B. (författare)
- Nutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany; University of Potsdam, Institute of Nutritional Science, Potsdam, Germany
-
- Travis, Ruth C. (författare)
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
-
- Vineis, Paolo (författare)
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
-
- Weiderpass, Elisabete (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Brennan, Paul (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Johansson, Mattias (författare)
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
-
- Richards, J Brent (författare)
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada/Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, QC, Montreal, Canada; Division of Endocrinology, Department of Medicine & Department of Human Genetics, McGill University, QC, Montreal, Canada; Department of Twin Research and Genetic Epidemiology, King's College London, Strand, London, United Kingdom
-
visa färre...
-
(creator_code:org_t)
- 2022
- 2022
- Engelska.
-
Ingår i: Cancer Epidemiology, Biomarkers and Prevention. - 1055-9965 .- 1538-7755. ; 31:10, s. 1966-1974
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Tobacco exposure causes 8 of 10 lung cancers, and identifying additional risk factors is challenging due to confounding introduced by smoking in traditional observational studies.MATERIALS AND METHODS: We used Mendelian randomization (MR) to screen 207 metabolites for their role in lung cancer predisposition using independent genome-wide association studies (GWAS) of blood metabolite levels (n = 7,824) and lung cancer risk (n = 29,266 cases/56,450 controls). A nested case-control study (656 cases and 1,296 matched controls) was subsequently performed using prediagnostic blood samples to validate MR association with lung cancer incidence data from population-based cohorts (EPIC and NSHDS).RESULTS: An MR-based scan of 207 circulating metabolites for lung cancer risk identified that blood isovalerylcarnitine (IVC) was associated with a decreased odds of lung cancer after accounting for multiple testing (log10-OR = 0.43; 95% CI, 0.29-0.63). Molar measurement of IVC in prediagnostic blood found similar results (log10-OR = 0.39; 95% CI, 0.21-0.72). Results were consistent across lung cancer subtypes.CONCLUSIONS: Independent lines of evidence support an inverse association of elevated circulating IVC with lung cancer risk through a novel methodologic approach that integrates genetic and traditional epidemiology to efficiently identify novel cancer biomarkers.IMPACT: Our results find compelling evidence in favor of a protective role for a circulating metabolite, IVC, in lung cancer etiology. From the treatment of a Mendelian disease, isovaleric acidemia, we know that circulating IVC is modifiable through a restricted protein diet or glycine and L-carnatine supplementation. IVC may represent a modifiable and inversely associated biomarker for lung cancer.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Smith-Byrne, Kar ...
-
Cerani, Agustin
-
Guida, Florence
-
Zhou, Sirui
-
Agudo, Antonio
-
Aleksandrova, Kr ...
-
visa fler...
-
Barricarte, Aure ...
-
Barranco, Miguel ...
-
Bochers, Christo ...
-
Gram, Inger Torh ...
-
Han, Jun
-
Amos, Christophe ...
-
Hung, Rayjean J.
-
Grankvist, Kjell
-
Nøst, Therese Ha ...
-
Imaz, Liher
-
Chirlaque-López, ...
-
Johansson, Mikae ...
-
Kaaks, Rudolf
-
Kühn, Tilman
-
Martin, Richard ...
-
McKay, James D.
-
Pala, Valeria
-
Robbins, Hilary ...
-
Sandanger, Torkj ...
-
Schibli, David
-
Schulze, Matthia ...
-
Travis, Ruth C.
-
Vineis, Paolo
-
Weiderpass, Elis ...
-
Brennan, Paul
-
Johansson, Matti ...
-
Richards, J Bren ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Cancer Epidemiol ...
- Av lärosätet
-
Umeå universitet